Author | Shreyaskumar Patel, MD


Chemotherapy for Soft-Tissue Sarcomas

January 15, 2015

ByVinod Ravi, MD|Shreyaskumar Patel, MD|Robert S. Benjamin, MD

In patients with high-risk localized disease, the use of systemic chemotherapy should be strongly considered to delay recurrence and/or reduce the patient’s risk of developing metastatic disease. In patients with metastatic disease, systemic chemotherapy remains the mainstay of treatment.